The Drug Controller General of India (DCGI) gave approval to another indigenous COVID-19 vaccine candidate called CORBEVAX for two clinical trials. Highlights Vaccine maker Biological E received approval...
The Drugs Controller General of India (DGCI) gave nod for Phase-2 and Phase-3 trails of India’s first mRNA-based COVID-19 vaccine. Highlights First mRNA-based covid-19 vaccine, called HGCO19, is...
The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D...
According to a lab study conducted in US, Delta variant of the SARS-CoV-2 virus cannot evade antibodies generated by vaccination. Key Points Findings were published in journal ‘Immunity’....
World Health Organisation (WHO) issued medical alerts on fake Covishield Vaccines in India. Key Points WHO has raised doubts on the genuineness of Covishield which is reaching patients...
Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it...
India allowed foreign nationals residing here to receive covid-19 vaccine by registering on the Co-Win portal on August 9, 2021. Highlights Foreigners can use their passport as identity...
India is to get its sixth Covid-19 vaccine soon as drug firm Zydus Cadila’s needle-free Covid-19 vaccine called ‘ZyCoV-D’ is all set to get emergency use authorisation (EUA)...
Indian Council of Medical Research (ICMR) in a study found that, mixed Covid immunisation routine, with a dose of Covishield followed by one of Covaxin, is safe and...
Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use India. With this vaccine, India has five Emergency Use Authorization vaccines. This move will further boost India’s collective...
United Arab Emirates (UAE) launched Covid-19 vaccines for children aged 3 to 17. Key Points UAE will administer China’s Sinopharm COVID-19 vaccine to children aged 3-17. This decision...
Indian Institute of Science (IISc) Bengaluru has developed a heat-tolerant COVID-19 vaccine formulation. While studying on animals, it was found to be effective against all current SARS-CoV-2 variants...
